Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer

NCT04022343 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma
Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v8

Interventions

DRUG: Cabozantinib

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]